Phi Life Sciences Launches Licensed Prostate Mitomic Test (PMT™) for Prostate Cancer Risk
Phi Life Sciences (Phi), a molecular diagnostic and laboratory service company that empowers physicians to deliver precision treatments and diagnostics to improve patient care and health, announced today that it has launched the Prostate Mitomic Test (PMT™) that is licensed from MDNA Life... - December 19, 2016
Phi Life Sciences Accepted as a Qualified Business to Raise Capital by the South Carolina Secretary of State
Phi Life Sciences has registered and been accepted by the Secretary of State of South Carolina to be a qualified business under the High Growth Small Business Job Creation Act of 2013 (S.C. Code of Laws §§ 11-44-10 et. seq.). As a qualified business, Phi Life Sciences is now eligible to... - November 03, 2016
Press Releases 1 - 2 of 2